Expertise in
3
conditions

Florin A. Caruntu

Bucharest, B, RO 
Expertise in
3
conditions
Bucharest, B, RO 

Overview

Florin Caruntu practices practicing medicine in Bucharest, Romania.

Mr. Caruntu is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Hepatitis D, Hepatitis, Hepatitis B, and Hepatitis C.

He is actively involved in clinical research, co-authoring 30 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Bucharest, B, Romania
Other Locations
Romania

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase 3, Randomized, Open-Label, Parallel Arm Study to Evaluate the Efficacy and Safety of 180 mcg Peginterferon Lambda-1a (Lambda) Subcutaneous Injection for 48 Weeks in Patients With Chronic Hepatitis Delta Virus (HDV) Infection (LIMT-2)
Phase 3, Randomized, Open-Label, Parallel Arm Study to Evaluate the Efficacy and Safety of 180 mcg Peginterferon Lambda-1a (Lambda) Subcutaneous Injection for 48 Weeks in Patients With Chronic Hepatitis Delta Virus (HDV) Infection (LIMT-2)
Enrollment Status: Unknown
Publish Date: August 25, 2023
Intervention Type: Drug
Study Drug: Peginterferon Lambda-1a
Study Phase: Phase 3
A Phase 3, Matrix Design, Partially Double-Blind, Randomized Study of the Efficacy and Safety of 50 mg Lonafarnib/100 mg Ritonavir BID With and Without 180 mcg PEG IFN-alfa-2a for 48 Weeks Compared With PEG IFN-alfa-2a Monotherapy and Placebo Treatment in Patients Chronically Infected With Hepatitis Delta Virus Being Maintained on Anti-HBV Nucleos(t)Ide Therapy (D-LIVR)
A Phase 3, Matrix Design, Partially Double-Blind, Randomized Study of the Efficacy and Safety of 50 mg Lonafarnib/100 mg Ritonavir BID With and Without 180 mcg PEG IFN-alfa-2a for 48 Weeks Compared With PEG IFN-alfa-2a Monotherapy and Placebo Treatment in Patients Chronically Infected With Hepatitis Delta Virus Being Maintained on Anti-HBV Nucleos(t)Ide Therapy (D-LIVR)
Enrollment Status: Completed
Publish Date: April 14, 2023
Intervention Type: Drug
Study Drugs: Lonafarnib, Ritonavir, PEG IFN-alfa-2a
Study Phase: Phase 3
View 1 Less Clinical Trial

30 Total Publications

From Diagnosis to Durability: A Review of the European Bulevirtide Experience and Practical Learnings for CHD Management.
From Diagnosis to Durability: A Review of the European Bulevirtide Experience and Practical Learnings for CHD Management.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: March 06, 2026

Frequently Asked Questions about Florin A. Caruntu

Is Florin A. Caruntu a top-rated expert for Hepatitis D?

MediFind is an objective health platform that identifies experts based on real-world data. Florin A. Caruntu is classified as an Elite expert for Hepatitis D, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Florin A. Caruntu participate in research or clinical trials?

Yes. Florin A. Caruntu has published 30 articles and abstracts on conditions like Hepatitis D. You can view a list of Florin A. Caruntu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Caruntu's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile